HIGHLIGHTS
- who: Rudolf, Götz and Michael, Sendtner from the Institute for Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany have published the article: Cooperation of Tyrosine Kinase Receptor TrkB and Epidermal Growth Factor Receptor Signaling Enhances Migration and Dispersal of Lung Tumor Cells, in the Journal: PLOS ONE | www.plosone.org of June/24,/2014
- what: The primary reason for the low cure rate from NSCLC is that about 70% of patients present with advanced disease, after the formation of metastatic spreading, and that even early stage NSCLC have a low overall survival rate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.